Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Daidone

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Cancer|August 1, 1985
Reliability of an in vitro short-term assay to predict the drug sensitivity of human breast cancerM G Daidone, R Silvestrini, O Sanfilippo, et al.
Basic and Applied Histochemistry|January 1, 1986
Breast cancer: implications of tumor cell kinetics on clinical outcomeM G Daidone, R Silvestrini, L Ventura, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1989
Cell kinetics as a prognostic indicator in node-negative breast cancerR Silvestrini, M G Daidone, P Valagussa, et al.
Anticancer Research|January 11, 2000
Cholesteryl butyrate in solid lipid nanospheres as an alternative approach for butyric acid deliveryC Pellizzaro, D Coradini, S Morel, et al.
British Journal of Cancer|April 17, 2008
High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcomaC J Cairney, S F Hoare, M-G Daidone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patientsR Silvestrini, E Benini, S Veneroni, et al.
International Journal of Cancer|July 18, 2000
Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancerR Silvestrini, A Luisi, M Zambetti, et al.
Gynecologic Oncology|October 1, 1989
Cell kinetics: a prognostic marker in epithelial ovarian cancerR Silvestrini, M G Daidone, G Bolis, et al.
European Journal of Cancer (Oxford, England : 1990)|September 29, 2001
Cell growth inhibition, G2M cell cycle arrest and apoptosis induced by the imidazoacridinone C1311 in human tumour cell linesN Zaffaroni, C De Marco, R Villa, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
p53 expression, DNA content and cell proliferation in primary and synchronous metastatic lesions from ovarian surface epithelial-stromal tumoursM G Daidone, E Benini, B Valentinis, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Cancer|August 1, 1985
Reliability of an in vitro short-term assay to predict the drug sensitivity of human breast cancerM G Daidone, R Silvestrini, O Sanfilippo, et al.
Basic and Applied Histochemistry|January 1, 1986
Breast cancer: implications of tumor cell kinetics on clinical outcomeM G Daidone, R Silvestrini, L Ventura, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1989
Cell kinetics as a prognostic indicator in node-negative breast cancerR Silvestrini, M G Daidone, P Valagussa, et al.
Anticancer Research|January 11, 2000
Cholesteryl butyrate in solid lipid nanospheres as an alternative approach for butyric acid deliveryC Pellizzaro, D Coradini, S Morel, et al.
British Journal of Cancer|April 17, 2008
High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcomaC J Cairney, S F Hoare, M-G Daidone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patientsR Silvestrini, E Benini, S Veneroni, et al.
International Journal of Cancer|July 18, 2000
Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancerR Silvestrini, A Luisi, M Zambetti, et al.
Gynecologic Oncology|October 1, 1989
Cell kinetics: a prognostic marker in epithelial ovarian cancerR Silvestrini, M G Daidone, G Bolis, et al.
European Journal of Cancer (Oxford, England : 1990)|September 29, 2001
Cell growth inhibition, G2M cell cycle arrest and apoptosis induced by the imidazoacridinone C1311 in human tumour cell linesN Zaffaroni, C De Marco, R Villa, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
p53 expression, DNA content and cell proliferation in primary and synchronous metastatic lesions from ovarian surface epithelial-stromal tumoursM G Daidone, E Benini, B Valentinis, et al.
Pageof 11